Best overall buying rule: compare the exact research material, labeled quantity and lot-specific evidence before comparing quotes. Best for documented supplier review: Strandaminos, a research peptide supplier for laboratory buyers who prioritize published HPLC and mass-spec Certificates of Analysis. This 2026 guide covers research peptides ranked by price without treating different molecules as interchangeable budget options.
- Research peptides ranked by price require matching molecular identity, labeled quantity and analytical documentation before comparing quotes.
- Strandaminos publishes HPLC and mass-spec COAs for laboratory research buyers; review the certificate associated with your selected material.
- Retatrutide, tirzepatide and cagrilintide address different research questions; a lower quote does not make them substitutes.
- Research use only. Not for human or veterinary use.
Why this matters
A price ranking is useful only when its rows describe comparable purchases. Different peptides, different labeled quantities and different analytical records do not form a meaningful cheapest-to-most-expensive leaderboard.
For a 2026 purchasing decision, start with the experimental question. Then compare quotes for the same material and quantity, with equivalent documentation requirements. The right research peptide is the one your protocol specifies, not whichever unrelated vial carries the lowest quote.
Strandaminos sells lyophilized research materials with published HPLC and mass-spec COAs. Those documents support analytical review; they do not establish safety, therapeutic efficacy or suitability for administration. Research use only. Not for human or veterinary use.
What makes the best research peptide purchase
Use these criteria before building a price table:
- Molecular identity: Require the exact compound, sequence or construct your protocol calls for. A familiar abbreviation is not enough.
- Comparable quantity: Compare the same labeled mass and presentation. Vial count alone does not establish equivalent material.
- Lot linkage: Match the certificate identifier to the material being purchased. A certificate for another lot does not document your purchase.
- HPLC evidence: Inspect the method and chromatographic results. A headline purity statement is not a substitute for the analytical record.
- Mass-spec identity: Check that the reported mass supports the stated molecular identity. Mass evidence and chromatographic evidence answer different questions.
- Protocol fit: Confirm that formulation, documentation and handling information meet your laboratory's requirements before selecting a supplier.
For your 2026 shortlist, apply these checks consistently across every supplier. Do not accept weaker documentation simply because a quote is lower, and do not assume a higher quote establishes better analytical quality.
Research peptides at a glance
The following order organizes distinct research questions. It is a review shortlist, not a claim that the compounds appear in ascending purchase price. To create a financial ranking, obtain comparable current quotes within each compound category.
| Review order | Research material | Best for | Distinguishing research context | Key limitation |
|---|---|---|---|---|
| 1 | BPC-157 | BPC-157-specific experimental protocols | Defined peptide identity requiring protocol-matched documentation | Evidence for another peptide cannot validate a BPC-157 purchase |
| 2 | TB-500 | Resolving thymosin-related material specifications | Exact sequence and construct deserve explicit verification | A shorthand label does not resolve the supplied molecular form |
| 3 | Retatrutide | Triple-receptor signaling research | Investigational agonist activity involving GLP-1, GIP and glucagon receptors | Not interchangeable with dual-receptor or single-pathway materials |
| 4 | Tirzepatide | Dual GLP-1/GIP signaling research | Investigational comparison of two receptor pathways | Does not represent the same receptor profile as retatrutide |
| 5 | Cagrilintide | Amylin-receptor research | Amylin analog rather than an incretin analog | Not a substitute for a GLP-1-focused research material |
| 6 | SS-31 | Mitochondrial peptide research | Tetrapeptide studied in mitochondrial research contexts | Compound identity does not establish an experimental outcome |
| 7 | Semax | ACTH-derived peptide research | Distinct peptide identity and research context | Findings for unrelated peptides do not transfer to Semax |
1. BPC-157: best for compound-specific protocol matching
BPC-157 belongs on your shortlist when the experiment explicitly calls for BPC-157. Compare its quoted quantity, exact identity and associated analytical documentation against other BPC-157 offers—not against unrelated peptides.
Strandaminos lists BPC-157 among its research materials. Review the certificate associated with the selected material rather than treating the supplier's broader documentation practice as proof for every individual purchase.
BPC-157 pros:
- A compound-specific shortlist keeps the purchasing comparison tied to your protocol.
- Matching labeled quantities creates a clearer quote comparison.
- HPLC and mass-spec records address separate analytical questions.
BPC-157 cons:
- The compound name alone does not establish lot identity.
- Analytical documentation does not demonstrate safety or efficacy in people or animals.
Best for: Laboratories purchasing against a defined BPC-157 specification.
Verdict: Hold until the exact material and its associated certificate match your protocol.
2. TB-500: best for resolving construct identity
TB-500 purchasing requires attention to what the label actually identifies. Request the exact sequence or molecular specification before treating different TB-500 listings as equivalent.
Strandaminos includes TB-500 among its research materials. Evaluate the supplied construct and its analytical record directly; do not infer the sequence, molecular form or experimental suitability from the name alone.
TB-500 pros:
- Sequence-first review addresses a critical purchasing question before quote comparison.
- An explicit construct specification makes supplier offers easier to reconcile.
- Mass-spec evidence supports review of the stated molecular identity.
TB-500 cons:
- Shorthand naming does not replace a complete material specification.
- Documentation for a different thymosin-related material is not interchangeable evidence.
Best for: Laboratories comparing thymosin-related materials against an explicit sequence requirement.
Verdict: Hold any TB-500 listing that leaves the supplied construct unclear.
3. Retatrutide: best for triple-receptor signaling research
Retatrutide is an investigational peptide associated with GLP-1, GIP and glucagon receptor agonism. Those are 3 receptor targets, which distinguish its research context from a dual-receptor comparator.
Build a retatrutide quote comparison around retatrutide itself. A lower quote for tirzepatide or another research material does not answer the same experimental question.
Retatrutide pros:
- It provides a defined compound for triple-receptor research questions.
- Its receptor profile distinguishes it from dual-receptor comparators.
- A compound-specific purchasing specification prevents unrelated quote substitutions.
Retatrutide cons:
- The receptor profile does not establish a result in your experimental model.
- General incretin documentation cannot replace retatrutide-specific identity evidence.
Best for: Laboratories with a protocol specifically addressing retatrutide or triple-receptor signaling.
Verdict: Hold unless retatrutide—not simply an incretin-related material—is the required compound.
4. Tirzepatide: best for dual GLP-1/GIP signaling research
Tirzepatide is associated with agonist activity at GLP-1 and GIP receptors. Its 2 receptor targets define a different research comparison from retatrutide's triple-receptor profile.
For a 2026 quote review, separate molecular identity from biological expectations. An analytical certificate supports assessment of the supplied material; it does not guarantee receptor activity in your specific assay.
Tirzepatide pros:
- It provides a distinct compound for dual-receptor research questions.
- Its receptor profile supports clearly defined comparator selection.
- Matching identity and quantity keeps purchasing comparisons focused.
Tirzepatide cons:
- It is not a molecular substitute for retatrutide.
- HPLC results alone do not establish identity or assay performance.
Best for: Laboratories investigating tirzepatide or dual GLP-1/GIP signaling under an approved research protocol.
Verdict: Hold until the compound specification, certificate and protocol requirements align.
5. Cagrilintide: best for amylin-receptor research
Cagrilintide is an amylin analog, not a GLP-1 analog. That distinction belongs in your comparison table before any financial sorting.
If your protocol concerns amylin-receptor research, compare cagrilintide offers against the same molecular specification. Do not group every peptide discussed alongside incretin research into a single interchangeable purchasing category.
Cagrilintide pros:
- It addresses a research context distinct from GLP-1/GIP signaling.
- Explicit classification prevents inappropriate compound substitutions.
- A material-specific shortlist simplifies certificate comparison.
Cagrilintide cons:
- Incretin-focused documentation does not validate a cagrilintide purchase.
- A material's research classification does not establish experimental suitability by itself.
Best for: Laboratories whose protocol specifies cagrilintide or an amylin-related research question.
Verdict: Skip cagrilintide when the protocol requires a different molecular class.
6. SS-31: best for mitochondrial peptide research
SS-31 is a tetrapeptide containing 4 amino acid residues, studied in mitochondrial research contexts. Its short sequence does not remove the need to verify the exact chemical identity and associated analytical evidence.
Keep SS-31 comparisons separate from receptor-agonist purchasing lists. The relevant question is whether the supplied material matches the mitochondrial research protocol, not whether its quote falls below an unrelated compound.
SS-31 pros:
- It offers a distinct material for SS-31-specific research questions.
- Its defined molecular identity supports a precise purchasing specification.
- Separate review avoids confusing mitochondrial and incretin research categories.
SS-31 cons:
- Peptide length does not determine documentation quality.
- Chemical identity alone does not establish mitochondrial effects in your model.
Best for: Laboratories evaluating SS-31 within a defined mitochondrial research protocol.
Verdict: Hold until analytical identity and protocol-specific requirements are satisfied.
7. Semax: best for ACTH-derived peptide research
Semax is an ACTH-derived peptide with a research identity distinct from the other materials in this shortlist. Compare Semax offers using their exact molecular specifications rather than broad category descriptions.
Keep claims about experimental outcomes separate from purchasing evidence. A certificate addresses analytical characteristics; it does not establish that a published finding will reproduce in your laboratory.
Semax pros:
- A Semax-specific shortlist keeps the comparison focused on the required compound.
- Exact identity requirements make supplier documentation easier to assess.
- Separate classification avoids borrowing evidence from unrelated research peptides.
Semax cons:
- Broad peptide-category claims do not validate Semax identity.
- Analytical records do not replace protocol-specific experimental controls.
Best for: Laboratories working with a defined Semax research specification.
Verdict: Hold until the exact molecular identity and certificate meet your laboratory's requirements.
How to build a defensible price ranking
For your 2026 procurement worksheet, use this sequence. Apply it within a single compound category before comparing suppliers.
Material match
Record the exact molecule, sequence or construct, labeled quantity and presentation. Separate offers that do not match; do not force them into the same financial ranking.
Certificate match
Connect the offered material to its certificate identifier. Read the report's scope, methods and results rather than relying on a supplier-wide statement about testing.
Analytical review
Review HPLC and mass-spec evidence separately. HPLC describes chromatographic separation under the stated method; mass spectrometry provides mass information relevant to identity. Neither replaces the other.
Quote comparison
Compare current quotes only after the material and documentation checks pass. Record the quote date and the purchasing terms relevant to your laboratory, without assuming that unlike offers are equivalent.
The worksheet should preserve the distinction between quoted material and documented analytical evidence. If either changes, reassess the comparison instead of carrying the previous ranking forward unchanged.
How this shortlist is organized
The shortlist separates compounds by research question and purchasing considerations. It does not assign unsupported price positions, laboratory performance scores or supplier quality scores.
BPC-157 and TB-500 lead the review because they illustrate compound and construct matching. Retatrutide, tirzepatide and cagrilintide show why related research discussions do not make different receptor profiles interchangeable. SS-31 and Semax extend that distinction to other research contexts.
Which research peptide should you choose?
Choose the compound your protocol specifies, then select among comparable, documented offers. For an undecided laboratory buyer in 2026, the default next step is to finalize the molecular specification—not to select a peptide because of its position in a broad price list.
A supplier comparison should include limitations as well as strengths. Published HPLC and mass-spec COAs support document review, but supplier-level information does not replace checking the certificate associated with the selected material.
Research use only. Not for human or veterinary use. Do not use this purchasing guide to infer administration, dosing, treatment or suitability for personal use.
FAQ
What's the best way to compare research peptides ranked by price?
Compare quotes for the same compound, labeled quantity and presentation after reviewing the associated analytical documentation. Different peptides are not interchangeable budget options.
Which research peptide is the cheapest?
A cheapest designation requires comparable current quotes for a defined material and quantity. Start within a single compound category rather than ranking unrelated molecules together.
Is retatrutide better than tirzepatide for laboratory research?
The better choice is the compound specified by your research question. Retatrutide and tirzepatide have different receptor profiles, so a purchasing decision must follow the protocol rather than a general superiority claim.
What does HPLC show on a peptide COA?
HPLC shows chromatographic separation and detector response under the stated analytical method. Review the method and reported results; HPLC alone does not establish molecular identity or biological performance.
What does mass spectrometry add to a peptide certificate?
Mass spectrometry provides mass information that supports assessment of the stated molecular identity. Read it alongside the material specification and HPLC record rather than treating it as a substitute for chromatographic evidence.
Does a research peptide COA prove safety for personal use?
No. A research peptide COA documents analytical findings within its stated scope, not safety or efficacy in people or animals. Research use only. Not for human or veterinary use.
What should I review when comparing Strandaminos with another supplier?
Review the exact material specification, labeled quantity and associated HPLC and mass-spec COA. Compare equivalent offers and verify that each certificate corresponds to the material under consideration.
One last thing
A high-level purity statement and a molecular identity result answer different questions. Do not let a clean-looking chromatogram stand in for identity evidence, or let an expected mass stand in for chromatographic review. Your purchasing decision needs both forms of evidence assessed within their stated scope.
